Sign Up to like & get
recommendations!
1
Published in 2022 at "Blood Advances"
DOI: 10.1182/bloodadvances.2022007569
Abstract: Key Points • Patients who underwent core needle biopsy are more likely to have poor-risk disease features and inadequate tissue for molecular analyses.• Increasing tissue requirements of biomarker-driven trials may exclude patients with high-risk DLBCL…
read more here.
Keywords:
increasing tissue;
trials may;
risk;
risk disease ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "PLOS Genetics"
DOI: 10.1371/journal.pgen.1010538
Abstract: ASNA1 plays an essential role in cisplatin chemotherapy response, type 2 diabetes, and heart disease. It is also an important biomarker in the treatment response of many diseases. Biochemically, ASNA1 has two mutually exclusive redox-modulated…
read more here.
Keywords:
function;
sensitivity;
elegans asna;
response ... See more keywords